MGISX
Price
$38.22
Change
-$0.16 (-0.42%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

MGISX vs RWIBX

Header iconMGISX vs RWIBX Comparison
Open Charts MGISX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Franchise R6
Price$38.22
Change-$0.16 (-0.42%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGISX vs RWIBX Comparison Chart
Loading...
VS
MGISX vs. RWIBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGISX is a Buy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. MGISX (2.92B). RWIBX pays higher dividends than MGISX: RWIBX (1.05) vs MGISX (0.91). MGISX was incepted earlier than RWIBX: MGISX (9 years) vs RWIBX (22 years). RWIBX is a more actively managed with annual turnover of: 27.00 vs. MGISX (15.00). RWIBX has a lower initial minimum investment than MGISX: RWIBX (250) vs MGISX (5000000). RWIBX annual gain was more profitable for investors over the last year : 23.75 vs. MGISX (18.15). RWIBX (42.68) and MGISX (42.62) have equivalent 5 years return.
MGISXRWIBXMGISX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD11.20213.56283%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.92B128B2%
Annual Yield % from dividends0.911.0587%
Returns for 1 year18.1523.7576%
Returns for 3 years11.007.37149%
Returns for 5 years42.6242.68100%
Returns for 10 yearsN/A49.04-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics